Admission Date:  [**2122-1-5**]              Discharge Date:   [**2122-1-24**]  Date of Birth:  [**2067-11-18**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 613**] Chief Complaint: Right leg pain and swelling  Major Surgical or Invasive Procedure: Temporary IVC filter placement Esophagogastroduodenoscopy colonoscopy   History of Present Illness: 54 y.o.
male with PMHx of ESRD (thought to be [**3-14**] HTN) s/p deceased donor kidney transplant in [**2111**], HTN and gout who presented to the ER with right leg swelling and pain x 3 days.
A Heparin gtt was started and the patient was admitted for further management.
[**3-14**] HTN s/p deceased donor renal transplant in [**2111**] Gout HTN Impaired glucose tolerance Hyperlipidemia   Social History: Born in [**Country 6257**], moved to US in [**2091**] at about age 23.
RENAL TRANSPLANT ULTRASOUND: A transplant kidney is seen in the right lower quadrant, measuring 12.4 cm.
[**2122-1-7**]: IVC filter placement IMPRESSION: Successful placement of retrievable Gunther tulip IVC filter via left common femoral vein approach.
Brief Hospital Course: Patient is a 54 year old male s/p renal transplant for ESRD ([**2111**]) without any identified risk factors for deep venous thrombosis.
He presented to the hospital with right lower extremity swelling and tenderness for 3 days.
Patient was started on a weight-based heparin drip at admission.
He was treated, with good effect, with oxycodone and acetominophen for pain.
Because of the size of the thrombus and the clinically significant threat of pulmonary embolus, an IVC filter was placed by interventional radiology on [**2122-1-7**].
No contast was used for placement because of patient's renal insufficiency and it was placed via ultrasound guidance.
Anticoagulation with heparin was held for procedures: filter placement and also endoscopy (see below).
Patient was continued on heparin until [**2122-1-13**] when he passed a grossly bloody stool in the morning.
Also increased Thrombin time which is expected given heparin anticoagulation.
Because of the risks involved in removal of the IVC including possible showering of emboli and difficulty removing due to fibrosis, the decision was made to leave the IVC filter in place, and as a result it will become a permanent IVC filter.
The patient was started on Coumadin on and his levels were carefully monitored given the potential interaction with his transplantation medications.
He was not a candidate for lovenox given his renal insufficency.
He was transferred to the intensive care unit at that time for further management, where he received two units of packed red blood cells, and an additional 1 unit two days later.
He was maintained on a twice daily proton pump inhibitor, which he should continue to take.
Due to interactions with his cyclosporine, patient was started on [**2122-1-19**] with a regimen of flagyl and tetracycline also with peptobismul to complete 14 day course.
He was continue Cyclosporine, Imuran and Prednisone.
His medications were renally dosed, and he received intravenous fluids with bicarbonate prior dye received while attempt was made to remove his IVC filter.
4 HTN - Patient's lopressor and enalapril home medications were discontinued initially at time of admission.
If indicated, his hydralazine and vasotec should be re-introduced as an outpatient.. .
Additionally, in consultation with the renal transplant team, the patient was started on a predisone taper.
This was started at 40 mg [**1-9**] and decreased 5 mg qday.
If not previously completed, the patient may benefit from a dianostic tap of a joint in the event of future gout flares to avoid higher doses of prednisone if his joint pain is not in fact gout.
At time of discharge, he was on tylenol 1000mg TID for left foot pain felt to be secondary to bumping his foot into his IV pole; the pain responded well to tylenol.
The trend improved with intravenous fluid repletion.
Glucose intolerance: Patient's blood glucose finger sticks trended back down to the normal range after his prednisone taper was completed.
He was maintained on a diabetic diet.
He was kept on a proton pump inhibitor, as well as a bowel regimen.
He had a mid-line placed during his stay due to access difficulties.
Medications on Admission: Colchicine 0.6 mg QD Hydralazine 50 mg [**Hospital1 **] Imuran 50 mg QD Lopressor 100 mg QD Cyclosporine 50 mg [**Hospital1 **] Prednisone 5 mg QD Probenecid 500 mg [**Hospital1 **] Vasotec 10 mg QD Ranitidine 150 mg [**Hospital1 **]   Discharge Medications: 1.
Colchicine 0.6 mg Tablet Sig: One (1) Tablet PO DAILY (Daily) as needed for Pain.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Bisacodyl 5 mg Tablet, Delayed Release (E.C.)
Azathioprine 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Cyclosporine Modified 25 mg Capsule Sig: Two (2) Capsule PO Q12H (every 12 hours).
Prednisone 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Metronidazole 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) for 8 days.
Bismuth Subsalicylate 262 mg Tablet, Chewable Sig: Two (2) Tablet PO QID (4 times a day) for 8 days.
Tetracycline 250 mg Capsule Sig: Two (2) Capsule PO Q12H (every 12 hours) for 8 days.
Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day).
Warfarin 1 mg Tablet Sig: One (1) Tablet PO DAILY16 (Once Daily at 16).
- Please have a CBC (blood counts) and Chemistry 7 (to check your creatinine) drawn within one week of discharge.
Azathioprine 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Secondary diagnoses: - Esophogeal ulcer - Colonic polyps (removed) - ESRD s/p deceased donor renal transplant in [**2111**] - Gout - HTN - Impaired glucose tolerance - Hyperlipidemia   Discharge Condition: Stable, ambulating without difficulty.
Discharge Instructions: You were admitted for treatment of a deep vein thrombosis.
You were treated with a filter in your inferior vena cava and also heparin to thin your blood.
These interventions were done so that the thrombosis would not move to your lung.
You were transitioned to an oral medication called Coumadin to thin your blood.
The levels of Coumadin will need to be followed closely.
Your hydralazine and enalapril were held while you were hospitalized due to bleeding.
